[Aphthosis of the oral cavity: therapeutic prospectives].
After analysing of recurrent aphthous stomatitis the clinical and morphological aspects, the authors consider various therapeutic possibilities. They underline the relationship between therapy and clinical aspects of the pathology.
Colella
G
G
Istituto di Chirurgia Orale e Maxillo Facciale, II Università degli Studi, Napoli.
Grimaldi
P L
PL
Tartaro
G P
GP
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000779:Anesthetics, Local / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001566:Benzocaine / Q000627:therapeutic use; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use; D010947:Plants, Toxic; D013281:Stomatitis, Aphthous / Q000188:drug therapy* / Q000517:prevention & control; D014030:Tobacco, Smokeless
D000305:Adrenal Cortex Hormones; D000779:Anesthetics, Local; D000900:Anti-Bacterial Agents; D008012:Lidocaine; D001566:Benzocaine
Aftosi del cavo orale: prospettive terapeutiche.